Eli Lilly (NYSE:LLY) plans to boost production of its popular ... which it markets for diabetes as Mounjaro and for ...
Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs.